Bill Commons

IA HF 2009

died on adjournment

A bill for an act relating to manufacturers and distributors of 340B drugs.

Iowa · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did IA HF 2009 pass?

No. IA HF 2009 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-21): Subcommittee recommends passage.

What is IA HF 2009 about?

IA HF 2009 is a bill in the 2026 Regular Session titled “A bill for an act relating to manufacturers and distributors of 340B drugs.”.

Who sponsors IA HF 2009?

BARKER is the primary sponsor of IA HF 2009.

Introduced
2026-01-13
Latest action
2026-01-21 — Subcommittee recommends passage.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • BARKERprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-01-21

    Subcommittee recommends passage.

    committee-passage-favorable

  2. 2026-01-21

    Subcommittee Meeting: 01/21/2026 4:00PM House Lounge 2.

  3. 2026-01-14

    Subcommittee: Barker, Bergan and Wilburn.

  4. 2026-01-13

    Introduced, referred to Health and Human Services.

    introduction,referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:44.236910Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=IA&identifier=HF 2009. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.